✦ LIBER ✦

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial

✍ Scribed by Carmela Loguercio; Pietro Andreone; Ciprian Brisc; Michaela Cristina Brisc; Elisabetta Bugianesi; Maria Chiaramonte; Carmela Cursaro; Mirela Danila; Ilario de Sio; Annarosa Floreani; Maria Antonietta Freni; Antonio Grieco; Marzia Groppo; Roberta Lazzari; Salvatore Lobello; Elisabetta Lorefice; Marzia Margotti; Luca Miele; Stefano Milani; Lajos Okolicsanyi; Giuseppe Palasciano; Piero Portincasa; Patrizia Saltarelli; Antonina Smedile; Francesco Somalvico; Aldo Spadaro; Ioan Sporea; Paolo Sorrentino; Raffaela Vecchione; Concetta Tuccillo; Camillo Del Vecchio Blanco; Alessandro Federico

Book ID: 113632606
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 426 KB
Volume: 52
Category: Article
ISSN: 0891-5849
DOI: 10.1016/j.freeradbiomed.2012.02.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lifestyle intervention and antioxidant t

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial

✍ Valerio Nobili; Melania Manco; Rita Devito; Vincenzo Di Ciommo; Donatella Compar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

No proven treatment exists for nonalcoholic fatty liver disease (NAFLD) in children and adolescents. We sought to determine the efficacy of lifestyle intervention with or without antioxidant therapy in pediatric NAFLD. A total of 53 patients (age 5.7-18.8 years, 37 boys) were included. Lifestyle int

825 SILYBIN CONJUGATED WITH PHOSPHATIDYL

825 SILYBIN CONJUGATED WITH PHOSPHATIDYLCHOLINE AND VITAMIN E IMPROVES LIVER DAMAGE IN PATIENTS WITH NAFLD: THE RESULTS OF A RANDOMIZED MULTICENTRE DOUBLE-BLIND VS PLACEBO TRIAL

✍ P. Andreone; M.C. Brise; M. Chiaramonte; A. Federico; A. Floreani; M.A. Freni; A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Clinical trial: a nutritional supplement

Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease

✍ E. VILAR GOMEZ; A. RODRIGUEZ DE MIRANDA; B. GRA ORAMAS; E. ARUS SOLER; R. LLANIO 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Treatment with insulin sensitizer metfor

Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial

✍ Elena Sofer; Mona Boaz; Zipora Matas; Margarita Mashavi; Marina Shargorodsky 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Assessment and management of comorbiditi

Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver disease

✍ Kathleen E. Corey; Raj Vuppalanchi 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 174 KB

Clinical model for distinguishing nonalc

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

✍ Nicole A. Palekar; Rhonda Naus; Steven P. Larson; John Ward; Stephen A. Harrison 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB